Upstate Active Clinical Trials Seeking Participants
Study title
Study Drug Versus Other Chemotherapeutic Agents For Third-Line Single Agent Treatment of Patients With Relapsed Aggressive Non-Hodgkin?s Lymphoma: A Randomized, Controlled, Phase III Comparative Trial.
IRB number
5035
What is the purpose of the study?
To determine the effectiveness and safety of the study drug with other chemotherapeutic agents.
Who is eligible?
Patients must be greater than 18 years of age, have not had any treatment in the past 30 days and failed two prior treatments for lymphoma.
What is involved if I participate?
- How long is the study?
6 months of treatment, 18 months of follow-up - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
No - What tests and procedures are involved?
Lab tests, x-rays/scans, physical exams, bone marrow biopsy/aspirate.
Who is the doctor administering the study?
Dr. Teresa Gentile
Where will the study take place?
SUNY Upstate Medical University, 750 East Adams Street, Syracuse, New York 13210
Over what time period is the study scheduled to run?
6/04 and continuing
Who can I contact for more information?
- Name: Joanne Chilton
- Phone: (315) 464-8240
- Email: chiltonj@upstate.edu
- Fax: (315) 464-8289
If you are interested in this trial, please contact the study coordinator or investigator noted above.
